This article is more than 5 years old. Information may no longer be current.

Novartis integrates ophthalmic unit into pharma division

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BASEL, Switzerland — Novartis plans to completely integrate the company's ophthalmics business unit into its pharmaceuticals division in a move to boost efficiency and save costs, company executives announced.

According to a Novartis press release, in mid-2003 the business unit's global headquarters will move from Bülach, Switzerland, to Basel. At the same time, the Swiss business will be moved into Novartis Pharma Switzerland in Berne.

At this time, the company does not foresee any staffing reductions as a result of the realignment or moves.